NewsRoom Articles - Page 3 of 239

ThursdayMar 14, 2024 10:00 am

Massachusetts Authorities Consider Regulating Intoxicants Derived from Hemp

During a legislative hearing last week, the commissioner of Massachusetts’ agriculture resources department was asked by Senator Michael Moore what she was doing about the spread of hemp products with extremely high THC doses. Ashley Randle, the commissioner, stated that her agency was aware of the issue and was working with the public health department to issue new guidance on how these hemp products needed to be treated. This was seen as a huge step forward, particularly since technically, hemp gummies and drinks with high THC doses aren’t legal in the state. Despite that, for some time now, the products…

TuesdayMar 12, 2024 3:00 pm

Hemp Firms in New York File Lawsuit to Quash New Rules

The Office of Cannabis Management is being sued by New York-licensed hemp companies in federal court. In a lawsuit filed earlier this month in the Southern District of New York, 10 hemp companies claimed that raids aimed at cracking down on the illicit marijuana market and the enforcement of revised hemp regulations had catastrophically affected their businesses. The crackdown came after the Cannabis Control Board approved a resolution to reduce the proliferation of products that contained cannabinoids derived from hemp and create a safe environment that would allow the state’s budding legal market to flourish. The defendants include the Office…

FridayMar 08, 2024 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Banking on DehydraTECH(TM) Technology for Major 2024 Growth

Lexaria, a global innovator in drug delivery platforms, has, since 2016, proven its patented DehydraTECH(TM) technology, asserting its superiority in improving drug bioavailability This has earned it 39 granted patents, with many pending globally DehydraTECH has a number of potential pharmaceutical applications with successful early stage results in hypertension, diabetes and weight loss and many others With its focus on GLP-1 clinical studies for 2024, Lexaria looks to carve out greater market share to make 2024 its biggest year Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has been pushing the envelope and redefining drug delivery technology.…

ThursdayMar 07, 2024 2:00 pm

South Dakota Legislation Targeting Hemp Intoxicants Poses Threat to CBD Market

South Dakota is one of the top hemp growers in the country. Now, a proposed measure intended to clamp down on products that contain high THC content and other cannabinoids may threaten this burgeoning CBD market. Last week, the state’s Senate regressed to a restrictive version of HB 1125, which had been amended previously. The amendments included in the measure that was approved by the House would have banned only products with synthetically processed, high-concentration compounds made from hemp. It would not have banned CBD and other extracts containing small amounts of cannabinoids that naturally occur in hemp flowers, such…

TuesdayMar 05, 2024 1:00 pm

Kansas Backtracks on Proposed Legislation Authorizing Hemp in Animal Feed

Legislators in Kansas have doubled back on a measure that would have legalized hemp in animal feed. Under federal law, hemp was legalized through the passage of the 2018 Farm Bill. The plant was subsequently removed from the list of controlled substances. Hemp is defined as the Cannabis sativa L. plant, and any part of it, including extracts, seeds, acids, isomers, cannabinoids and salts, among others, with not more than 0.3% of THC. Despite legalizing overall use of hemp, the Farm Bill did not allow the use of hemp or hemp products in food for animals or humans. HB 2168,…

ThursdayFeb 29, 2024 1:30 pm

Advocates Voice Concerns as Bill Restricting Hemp Clears Wyoming Senate, Heads to House

Last week, Senate File 32 completed its third reading in the Wyoming senate. The bill has now been forwarded to the state’s House of Representatives. From there, it will be forwarded to undergo committee review and then be debated on the floor. If no amendments are proposed, it will be advanced to the governor’s desk for his veto or approval. This bill seeks to impose a limitation on psychoactive substances and would eliminate the ability of anyone to sell hemp products that contained HHCo, delta-10, delta-8 and other products with low THC content in the state. This puts independently owned…

TuesdayFeb 27, 2024 3:00 pm

Hemp Emerges as Viable Green-Building Material

A nonpsychoactive variant of cannabis called hemp is emerging as a renewable alternative to traditional building materials. Long before cannabis prohibition effectively banned the cultivation of all types of cannabis, hemp was used for centuries to make everything from clothes and ropes to sails and riggings in ships. However, hemp cultivation and use in the United States was prohibited for several decades until Congress legalized the cannabis variant via the 2018 Farm Bill. With many states launching individual hemp programs in the years after, hemp has attracted significant attention because of its many potential applications. One of the more revolutionary…

TuesdayFeb 27, 2024 11:15 am

Astrotech Corp. (NASDAQ: ASTC) Reports 512% Jump in YTD Revenue

Astrotech reported financial results for the quarter ended December 31, 2023, recording year-to-date revenue of $1,540,000 The company attributed the growth to the successful fulfillment of two significant purchase orders for the TRACER 1000(TM), the world’s first mass spectrometer-based explosive trace detectors (“ETD”), to customers in Romania Astrotech is focused on commercializing its innovative platform mass spectrometry technology through its wholly owned subsidiaries 1st Detect Corp., AgLAB Inc., Pro-Control Inc., and BreathTech Corp. The company and its subsidiaries are positioned to capitalize on burgeoning markets, including the global mass spectrometry market, expected to grow from an estimated $6.77 billion in…

TuesdayFeb 27, 2024 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Closing of $3.6 Million Registered Direct Offering

Lexaria, a global innovator in drug delivery platforms, just announced $3.6 million in gross proceeds from its registered direct offering priced at the market The proceeds will go to critical R&D studies, patent, and legal costs, as well as general working capital purposes This is timely, given Lexaria’s resolve to double down on GLP-1 investigations for the 2024 calendar year Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced that the registered direct offering for the purchase and sale of 1,558,443 shares of common stock at a purchase price of $2.31 – at the market under…

ThursdayFeb 22, 2024 1:00 pm

Florida Moves Closer to Outlawing Delta-8 Products from Hemp

Florida may soon ban delta-8 products such as vapes, edible gummies and joints. This comes after senators approved a measure that would prevent naturally occurring or synthetic delta-8 and delta-10 from being sold legally as hemp products. Delta-8 and delta-10 can produce a psychoactive high when consumed. Delta-8 is a naturally occurring tetrahydrocannabinol (“THC”) compound; THC is one of the two main psychoactive compounds found in the marijuana plant, the other being cannabidiol (“CBD”). An identical measure in Florida’s house, HB 1613, may soon be voted on. The senate measure in question, SB 1698, would impose a limit on the…